SEC Form 4 · accession 0001213900-26-086433
Park Ha Biological Technology Co., Ltd. · BYAH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Xiaoyan Zhu
Officer — CFO
Period of report
Aug 3, 2026
Accepted (ET)
Aug 7, 2026 · 8:58 am EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001986247
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary SharesF2,F1 | Aug 3, 2026 | A | 112,500 | $0.18 | A | 112,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Purchase of Class A ordinary shares from Park Ha Biological Technology Co., Ltd. pursuant to its 2026 Share Incentive Plan.
- F2On August 6, 2026, Park Ha Biological Technology Co., Ltd. effected a 1-for-8 reverse stock split (the "Reverse Stock Split"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.